HU0700051D0 - Treatment of gastrointestinal disorders associated with enhanced motility and inflammation using kynurenic acid - Google Patents

Treatment of gastrointestinal disorders associated with enhanced motility and inflammation using kynurenic acid

Info

Publication number
HU0700051D0
HU0700051D0 HU0700051A HUP0700051A HU0700051D0 HU 0700051 D0 HU0700051 D0 HU 0700051D0 HU 0700051 A HU0700051 A HU 0700051A HU P0700051 A HUP0700051 A HU P0700051A HU 0700051 D0 HU0700051 D0 HU 0700051D0
Authority
HU
Hungary
Prior art keywords
inflammation
treatment
disorders associated
gastrointestinal disorders
kynurenic acid
Prior art date
Application number
HU0700051A
Other languages
Hungarian (hu)
Original Assignee
Univ Szegedi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Szegedi filed Critical Univ Szegedi
Priority to HU0700051A priority Critical patent/HUP0700051A2/en
Publication of HU0700051D0 publication Critical patent/HU0700051D0/en
Priority to PCT/HU2008/000005 priority patent/WO2008087461A2/en
Publication of HUP0700051A2 publication Critical patent/HUP0700051A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0700051A 2007-01-17 2007-01-17 Use of kynurenic acid and derivatives there of for treating of gastrointestinal disorders associated with enhanced motility and inflammation HUP0700051A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0700051A HUP0700051A2 (en) 2007-01-17 2007-01-17 Use of kynurenic acid and derivatives there of for treating of gastrointestinal disorders associated with enhanced motility and inflammation
PCT/HU2008/000005 WO2008087461A2 (en) 2007-01-17 2008-01-15 Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0700051A HUP0700051A2 (en) 2007-01-17 2007-01-17 Use of kynurenic acid and derivatives there of for treating of gastrointestinal disorders associated with enhanced motility and inflammation

Publications (2)

Publication Number Publication Date
HU0700051D0 true HU0700051D0 (en) 2007-03-28
HUP0700051A2 HUP0700051A2 (en) 2008-09-29

Family

ID=89987271

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0700051A HUP0700051A2 (en) 2007-01-17 2007-01-17 Use of kynurenic acid and derivatives there of for treating of gastrointestinal disorders associated with enhanced motility and inflammation

Country Status (2)

Country Link
HU (1) HUP0700051A2 (en)
WO (1) WO2008087461A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL228037B1 (en) * 2009-03-23 2018-02-28 Marciniak Agnieszka Maria Application of kynurenic acid and its derivatives in preventing or treatment of pancreas diseases
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
KR102294405B1 (en) * 2013-06-05 2021-08-25 더 유니버시티 오브 브리티쉬 콜롬비아 Anti-fibrogenic compounds, methods and uses thereof
EP3022558A4 (en) * 2013-07-18 2017-02-15 Dianti MS Limited Method and prognostic kit for monitoring multiple sclerosis (ms)
HUP1600179A2 (en) 2016-03-04 2017-09-28 Univ Szegedi Novel c-3 substituted kynurenic acid derivatives with improved neuroprotective activity
FR3055548B1 (en) * 2016-09-05 2018-09-28 Metabrain Research USE OF METABOLITES OF TRYPTOPHAN IN THE TREATMENT OF MUSCLE ATROPHY
PL234411B1 (en) 2017-01-20 2020-02-28 Milart Pawel Improved formula of preparations for oral and enteral nutrition of children
EP3817746A4 (en) * 2018-07-06 2022-04-06 Algernon Pharmaceuticals Inc. Compounds for treatment of inflammatory bowel disease and methods thereof
EP4162946A1 (en) * 2021-10-05 2023-04-12 Institut national de recherche pour l'agriculture, l'alimentation et l'environnement Kynurenine aminotransferase and products thereof for the treatment of inflammatory bowel diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093813A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders

Also Published As

Publication number Publication date
WO2008087461A2 (en) 2008-07-24
WO2008087461A3 (en) 2008-09-18
HUP0700051A2 (en) 2008-09-29
WO2008087461B1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
HRP20190059T1 (en) Compositions for the treatment of pain and/or inflammation
HU0700051D0 (en) Treatment of gastrointestinal disorders associated with enhanced motility and inflammation using kynurenic acid
EP2424464A4 (en) Devices and methods for treating gastrointestinal and metabolic disorders
HK1198162A1 (en) Compounds and methods in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
IL185396A0 (en) Methods of treating gastrointestinal inflammation
IL205548A0 (en) Compositions for the treatment of inflammation of the gastrointestinal tract
ZA201100974B (en) Treatment of autoimmune and inflammatory disease
EP2281188A4 (en) Photoacoustic imaging devices and methods of making and using the same
EP2157919A4 (en) Endoscopic delivery devices and methods
EP1978876A4 (en) Devices and methods for gastrointestinal stimulation
GB0904044D0 (en) The treatment of inflammatory disorders and pain
GB0719577D0 (en) Microimplant devices and methods of making and use thereof
EP2182952A4 (en) Treatment of post-traumatic stress disorder
ZA200905101B (en) Diagosis and treatment of preeclampsia
EP1996218A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
IL195712A0 (en) Treatment of gastrointestinal disorders with cgrp-antagonists
GB0705488D0 (en) Treatment of inflammation and/or endotoxic shock
IL211459A0 (en) Pancreatic polypeptide and variants thereof for use in the treatment of intestinal disorders
PT2222330T (en) Treatment of inflammatory illnesses with ace2
EP2488198A4 (en) Treatment and diagnosis of inflammatory disorders
GB0604826D0 (en) The treatment of inflammatory disorders and pain
EP2327407A4 (en) Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
GB0604822D0 (en) The treatment of inflammatory disorders and pain
TWI365498B (en) Manufacturing methods of asymmetric bump and pixel structure
GB0819446D0 (en) Treatment of inflammatory disorders

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees